ZFIN ChEBI: glycerophosphoserine

Relationships

is a type of: glycerophospholipid serine derivative

glycerophospholipid serine derivative Show first 5 Terms
has subtype: 1-(2-methoxy-5Z,19Z-hexacosadienyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-5Z-hexadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-heptadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-hexadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-pentadecenyl)-sn-glycero-3-phosphoserine ... Show All 75 Terms

1-(2-methoxy-5Z,19Z-hexacosadienyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-5Z-hexadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-heptadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-hexadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-pentadecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-6Z-tetradecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-13-methyl-6Z-tetradecenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-13-methyl-tetradecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-14-methyl-pentadecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-16Z-tricosenyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-eicosanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-heneicosanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-hexadecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-nonadecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-octadecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-pentadecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-tetracosanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-tetradecanyl)-sn-glycero-3-phosphoserine 1-(2-methoxy-tricosanyl)-sn-glycero-3-phosphoserine 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoserine 1-acyl-2-hydroxy-sn-glycero-3-phospho-(N-acyl)-serine(2-) 1-alkyl-sn-glycero-3-phospho-L-serine acylglycerophosphoserine alkyl,acyl-sn-glycero-3-phosphoserine phosphatidylserine O-18:0/0:0 PS(O-16:0/0:0) PS(O-16:0/12:0) PS(O-16:0/13:0) PS(O-16:0/18:2(9Z,12Z)) PS(O-16:0/19:1(9Z)) PS(O-16:0/20:0) PS(O-16:0/20:2(11Z,14Z)) PS(O-16:0/21:0) PS(O-16:0/22:2(13Z,16Z)) PS(O-18:0/12:0) PS(O-18:0/13:0) PS(O-18:0/17:2(9Z,12Z)) PS(O-18:0/18:0) PS(O-18:0/18:2(9Z,12Z)) PS(O-18:0/18:3(6Z,9Z,12Z)) PS(O-18:0/19:0) PS(O-18:0/20:3(8Z,11Z,14Z)) PS(O-18:0/22:2(13Z,16Z)) PS(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PS(O-20:0/0:0) PS(O-20:0/14:0) PS(O-20:0/16:0) PS(O-20:0/16:1(9Z)) PS(O-20:0/17:0) PS(O-20:0/18:3(6Z,9Z,12Z)) PS(O-20:0/18:3(9Z,12Z,15Z)) PS(O-20:0/20:2(11Z,14Z)) PS(O-20:0/20:4(5Z,8Z,11Z,14Z)) PS(O-20:0/22:4(7Z,10Z,13Z,16Z)) PS(O-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) PS(P-16:0/0:0) PS(P-16:0/12:0) PS(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) PS(P-16:0/22:2(13Z,16Z)) PS(P-18:0/0:0) PS(P-18:0/12:0) PS(P-18:0/16:1(9Z)) PS(P-18:0/17:1(9Z)) PS(P-18:0/17:2(9Z,12Z)) PS(P-18:0/20:2(11Z,14Z)) PS(P-18:0/22:0) PS(P-18:0/22:2(13Z,16Z)) PS(P-20:0/0:0) PS(P-20:0/15:1(9Z)) PS(P-20:0/17:0) PS(P-20:0/17:2(9Z,12Z)) PS(P-20:0/18:0) PS(P-20:0/18:2(9Z,12Z)) PS(P-20:0/20:5(5Z,8Z,11Z,14Z,17Z)) PS(P-20:0/22:4(7Z,10Z,13Z,16Z)) Show first 5 Terms

Phenotype

Phenotype resulting from glycerophosphoserine

Phenotype where environments contain glycerophosphoserine

Phenotype modified by environments containing glycerophosphoserine

Human Disease Model